The drug development sector in the United States is experiencing a substantial surge in requirement for Tirzepatide APIs. This potent medication, used to treat type 2 diabetes, has attracted considerable attention from both individuals and healthcare professionals. As a result, numerous manufacturers have emerged as makers of Tirzepatide APIs in th